Amoy Diagnostic Co. goes public on Shenzhen stock exchange, specialist in tumor analysis

Aug 2, 2017

The company has independent IP for nucleic acid molecular detection technology (ADx-ARMS ®) and is specialized in the detection of tumor-related genes such EGFR, KRAS, BRAF, EML4-ALK, PIK3CA, ROS1, NRAS, Her-2 and other.

China Bio news release, August 2, 2017

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny